Clinical Trial Update: Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update for AZR-MD-001 addressing Meibomian Gland Dysfunction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction

Drugs mentioned

• AZR-MD-001

Snippet

Sponsor: Azura Ophthalmics | Conditions: Meibomian Gland Dysfunction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-01-25